In8Bio INAB
NASDAQ INAB
$1.40 +0.07 (+5.26%)
At close: Oct 1, 2026 · 4:00 PM EDT

In8Bio (INAB) Total Debt (2020 - 2021)

Updated

In8Bio (INAB) reported Total Debt of $174,000 for Q2 2021.

Analysis

In8Bio (INAB) Total Debt (2020 - 2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 49.04 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 70.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 53.91 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 37.49 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -111.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 57.30 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 26.25 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 63.19 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 In8Bio 25.89 Mn 25.89 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 174,000.00
Dec 31, 2020 174,000.00
API Access

In8Bio Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=INAB&period=max&api_key=YOUR_API_KEY